相关实验视频
Updated: Jul 8, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
共享决策,提高在中国门诊中腹主导刺激性肠综合征的疗效:一项前性随机对照试验的协议
Kai Song1, Zhengyang Fan1, Yang Chen1
1Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
共享决策 (SDM) 可能改善腹主导性易怒肠综合征 (IBS-D) 的治疗. 这项研究调查了SDM.
科学领域:
- 胃肠病学 胃肠病学
- 临床试验 临床试验
- 以患者为中心的护理
背景情况:
- 腹占主导地位的刺激性肠综合征 (IBS-D) 在评估和治疗方面存在复杂的挑战,原因是多因素的致病性,通常包括心理社会方面.
- 对于IBS-D的传统治疗方法可能不会始终产生令人满意的结果,导致患者不满,并希望更多地参与临床决策.
- 共享决策 (SDM) 通过提高患者的遵从性和满意度,在其他医疗状况中表现出有效性,但其对IBS-D的影响仍未得到验证.
研究的目的:
- 评估共享决策 (SDM) 模型在改善腹主导性刺激性肠综合征 (IBS-D) 患者治疗结果方面的有效性.
- 评估SDM对IBS-D患者症状严重程度,疾病影响,生活质量和心理健康的影响.
- 在SDM框架下探索患者和医生对诊断和治疗过程的评估.
主要方法:
- 一项前性,随机化,单中心试验,涉及166名在北京联合医学院医院被诊断患有IBS-D的门诊患者.
- 参与者将被分配到常规治疗组或共享决策 (SDM) 组.
- 主要结局指标是使用IBS症状严重程度表来评估肠道症状的严重程度,其次要终点包括疾病影响,生活质量,心理状态和过程评估.
主要成果:
- 该研究正在进行中;结果预计将在研究完成后公布.
- 将分析IBS症状严重程度的主要终点数据.
- 将收集和分析有关生活质量和心理因素的二次终点数据.
结论:
- 这项临床试验旨在提供证据,证明共享决策 (SDM) 在管理腹主导性易怒肠综合征 (IBS-D) 的有效性.
- 预期的发现表明,SDM可以提高治疗结果和IBS-D管理中的患者满意度.
- 结果将被传播,以在胃肠道医生中为临床实践提供信息.
更多相关视频
04:04Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: